Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

The presence of tumor immune infiltrating cells (TILs), particularly CD8(+) T-cells, is a robust predictor of outcome in patients with colorectal cancer (CRC). We revisited TIL abundance specifically in patients with microsatellite stable (MSS) CRC without evidence of lymph node or metastatic spread...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Millen, Rosemary, Malaterre, Jordane, Cross, Ryan S., Carpinteri, Sandra, Desai, Jayesh, Tran, Ben, Darcy, Phillip, Gibbs, Peter, Sieber, Oliver, Zeps, Nikolajs, Waring, Paul, Fox, Stephen, Pereira, Lloyd, Ramsay, Robert G.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006930/
https://ncbi.nlm.nih.gov/pubmed/27622014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1149667
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars